Persistent Middle Cerebral Artery Reverse End-Diastolic Flow in Severe Pre-eclampsia: A Rare Case with Adverse Neonatal Outcome
International Journal of Innovative Science and Research Technology · 24.03.2026 · 1934
DOI: 10.38124/ijisrt/26mar1095 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 24.03.2026. Verfasst von N. Chaitanya und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Middle cerebral artery (MCA) Doppler assessment is an important tool in evaluating fetal well-being. Normally, the MCA demonstrates high-resistance flow, but in hypoxic states it becomes low resistance due to the brain-sparing effect. In advanced compromise, reverse end-diastolic flow (REDF) may occur, indicating severe pathology. Persistent MCA-REDF is rare and associated with poor fetal and neonatal outcomes. We report a case of persistent MCA-REDF at 30 weeks of gestation in a pregnancy complicated by severe pre-eclampsia, resulting in neonatal death despite timely intervention.
Zitieren
APA
Chaitanya, N., ., J., ., D., & Neha, S. (2026). Persistent Middle Cerebral Artery Reverse End-Diastolic Flow in Severe Pre-eclampsia: A Rare Case with Adverse Neonatal Outcome. International Journal of Innovative Science and Research Technology, 1934. https://doi.org/10.38124/ijisrt/26mar1095
Vancouver
Chaitanya N, . J, . D, Neha S. Persistent Middle Cerebral Artery Reverse End-Diastolic Flow in Severe Pre-eclampsia: A Rare Case with Adverse Neonatal Outcome. International Journal of Innovative Science and Research Technology. 2026:1934. doi:10.38124/ijisrt/26mar1095
BibTeX
@article{Chaitanya2026,
author = {Chaitanya, N. and ., Juveriya and ., Deepthisri and Neha, Sumera},
title = {Persistent Middle Cerebral Artery Reverse End-Diastolic Flow in Severe Pre-eclampsia: A Rare Case with Adverse Neonatal Outcome},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {1934},
doi = {10.38124/ijisrt/26mar1095}
}
EUVIMED